CI
The Cigna Group
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
+2/100
Last price
274.37
▲ 3.08 (1.14%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
271.12
Prev close
271.29
Day high
275.81
Day low
270.00
Volume
1.09M
Market cap
$72.50B
P/E (TTM)
11.34
52W range
239.51 – 312.18
Day trading desk
Gap from prior close
-0.06%
Prior close 271.29
VWAP
273.50
+0.32% from price
Relative volume
1.27×
Normal
Session range
2.16%
270.00 – 275.82
Position in range
75%
Near session high
ATR (14D)
6.97
2.54% of price
Prior day high
273.11
PDH
Prior day low
266.46
PDL
Bid / ask spread
—
Quote not published
Session volume
2.11M
Avg 1.66M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.32%
-2.3%
1M
-2.88%
-4.0%
3M
-5.30%
-9.8%
6M
+0.04%
-18.1%
YTD
-0.31%
-14.6%
1Y
-11.78%
-28.2%
3Y
-4.09%
-86.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+14.21K
Net buying
Buy transactions
14
239.72K shares
Sell transactions
5
225.51K shares
Net transactions
+19
Buys less sells
Sell : buy shares
0.9 : 1
Mixed
Insider-held shares
3.82M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 3, 26 | NEVILLE EVERETT Officer |
SELL | 617 | $175.26K | Direct |
| Sep 1, 26 | EVANKO BRIAN C Chief Executive Officer |
STOCK | 3.11K | $0 | Direct |
| Aug 18, 26 | JONES NICOLE S. Officer |
SELL | 2.68K | $748.52K | Direct |
| Aug 5, 26 | JONES NICOLE S. Officer |
CONVERSION | 15.35K | $2.95M | Direct |
| Aug 4, 26 | JONES NICOLE S. Officer |
SELL | 19.44K | $5.37M | Direct |
| Jun 12, 26 | KATES JAMIE G Officer |
SELL | 899 | $268.45K | Direct |
| Jun 12, 26 | KATES JAMIE G Officer |
CONVERSION | 899 | $137.45K | Direct |
| May 13, 26 | CORDANI DAVID M Chief Executive Officer |
CONVERSION | 212.54K | $36.21M | Direct |
| May 12, 26 | CORDANI DAVID M Chief Executive Officer |
SELL | 201.88K | $59.11M | Direct |
| Apr 22, 26 | MCCLELLAN MARK B Director |
STOCK | 782 | $0 | Direct |
| Apr 22, 26 | OZUAH PHILLIP Director |
STOCK | 782 | $0 | Direct |
| Apr 22, 26 | HATHI NEESHA Director |
STOCK | 782 | $0 | Direct |
| Apr 22, 26 | ROSS KIMBERLY A Director |
STOCK | 782 | $0 | Direct |
| Apr 22, 26 | KURIAN GEORGE Director |
STOCK | 782 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BRAILER DAVID J |
Officer | 17.82K | Stock Award(Grant) |
CORDANI DAVID M |
Chief Executive Officer | 658.30K | Conversion of Exercise of derivative security |
DENNISON ANN M |
Chief Financial Officer | 7.75K | Stock Award(Grant) |
EDER NOELLE K |
Officer | 13.59K | Sale |
EVANKO BRIAN C |
Chief Executive Officer | 67.56K | Stock Award(Grant) |
FOSS ERIC J. |
Director | 36.70K | Stock Award(Grant) |
JONES NICOLE S. |
Officer | 27.33K | Sale |
PALMER ERIC P. |
Officer | 67.89K | Stock Award(Grant) |
WISEMAN ERIC C |
Director | 23.94K | Stock Award(Grant) |
ZARCONE DONNA F |
Director | 27.52K | Stock Award(Grant) |
Fundamentals
Market cap$72.50B
Enterprise value$97.41B
Revenue (TTM)$282.38B
Gross profit$25.80B
EBITDA$12.76B
Net income$6.42B
EPS (TTM)$24.19
Free cash flow$7.98B
Total cash$7.26B
Total debt$31.88B
Book value / share$161.62
Shares outstanding264.24M
Float262.92M
Short % of float2.77%
Dividend yield2.27%
Beta (5Y)0.30
Valuation & profitability ratios
Trailing P/E11.34
Forward P/E8.19
PEG ratio0.74
Price / sales—
Price / book1.70
EV / revenue0.35
EV / EBITDA7.64
Gross margin9.14%
Operating margin3.98%
Profit margin2.27%
Return on equity16.76%
Return on assets4.46%
Debt / equity74.29
Current ratio0.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $273.85B | $246.15B | $194.10B | $179.36B | +11.3% |
| Operating revenue | $256.93B | $231.36B | $181.48B | $168.48B | +11.1% |
| Cost of revenue | $249.34B | $221.16B | $170.09B | $157.02B | +12.7% |
| Gross profit | $24.51B | $24.99B | $24.01B | $22.34B | -1.9% |
| Selling, general & admin | $14.62B | $14.84B | $14.82B | $13.17B | -1.5% |
| Total operating expense | $16.36B | $16.55B | $16.64B | $15.05B | -1.1% |
| Operating income | $8.15B | $8.44B | $7.37B | $7.29B | -3.4% |
| Net interest income | -$1.41B | -$1.44B | -$1.45B | -$1.23B | +1.9% |
| Pre-tax income | $7.78B | $5.27B | $5.51B | $8.40B | +47.7% |
| Tax provision | $1.49B | $1.49B | $141.00M | $1.61B | +0.1% |
| Net income | $5.96B | $3.43B | $5.16B | $6.70B | +73.5% |
| Net income to common | $5.96B | $3.43B | $5.16B | $6.70B | +73.5% |
| Basic EPS | 22.33 | 12.54 | 17.65 | 22.33 | +78.0% |
| Diluted EPS | 22.18 | 12.12 | 17.39 | 21.30 | +83.0% |
| EBIT | $9.19B | $6.70B | $6.96B | $9.63B | +37.1% |
| EBITDA | $11.96B | $9.48B | $9.99B | $12.56B | +26.2% |
| Basic shares | 266.74M | 273.79M | 292.50M | 298.68M | -2.6% |
| Diluted shares | 268.56M | 283.22M | 296.88M | 313.06M | -5.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.68B | $7.55B | $7.82B | $5.92B | +1.7% |
| Cash & short-term investments | $8.65B | $8.21B | $8.56B | $6.76B | +5.2% |
| Accounts receivable | $28.77B | $24.23B | $17.72B | $17.22B | +18.7% |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | +9.7% |
| Total current assets | $47.81B | $48.87B | $37.35B | $30.12B | -2.2% |
| Property, plant & equipment | $3.65B | $3.65B | $3.69B | $3.77B | -0.1% |
| Goodwill & intangibles | $73.48B | $73.79B | $75.12B | $78.30B | -0.4% |
| Total assets | $157.92B | $155.88B | $152.76B | $143.88B | +1.3% |
| Total current liabilities | $56.34B | $57.98B | $48.72B | $41.23B | -2.8% |
| Current debt | $592.00M | $3.04B | $2.77B | $2.99B | -80.5% |
| Long-term debt | $30.87B | $28.94B | $28.16B | $28.10B | +6.7% |
| Total debt | $31.46B | $31.97B | $30.93B | $31.09B | -1.6% |
| Total liabilities | $116.05B | $114.64B | $106.41B | $99.13B | +1.2% |
| Retained earnings | $47.87B | $43.52B | $41.65B | $37.94B | +10.0% |
| Shareholder equity | $41.71B | $41.03B | $46.22B | $44.67B | +1.7% |
| Working capital | -$8.53B | -$9.11B | -$11.37B | -$11.10B | +6.4% |
| Net tangible assets | -$31.77B | -$32.75B | -$28.90B | -$33.63B | +3.0% |
| Shares issued | 404.60M | 402.51M | 399.89M | 397.82M | +0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $6.29B | $3.78B | $5.37B | $6.78B | +66.4% |
| Depreciation & amortisation | $2.77B | $2.77B | $3.04B | $2.94B | 0.0% |
| Change in working capital | -$261.00M | $418.00M | $3.02B | $259.00M | -162.4% |
| Operating cash flow | $9.60B | $10.36B | $11.81B | $8.66B | -7.4% |
| Capital expenditure | -$1.21B | -$1.41B | -$1.57B | -$1.29B | +13.8% |
| Investing cash flow | -$4.41B | -$2.10B | -$5.17B | $3.10B | -109.7% |
| Share buybacks | -$3.62B | -$7.03B | -$2.28B | -$7.61B | +48.5% |
| Dividends paid | -$1.61B | -$1.57B | -$1.45B | -$1.38B | -2.8% |
| Financing cash flow | -$6.42B | -$7.65B | -$4.29B | -$11.24B | +16.0% |
| Free cash flow | $8.39B | $8.96B | $10.24B | $7.36B | -6.3% |
| End cash position | $7.74B | $8.93B | $8.34B | $5.98B | -13.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $71.40B | $68.29B | $72.13B | $69.52B | $66.94B | +4.5% |
| Operating revenue | $67.03B | $63.85B | $67.62B | $65.14B | $62.80B | +5.0% |
| Cost of revenue | $65.13B | $62.02B | $66.06B | $63.37B | $61.02B | +5.0% |
| Gross profit | $6.26B | $6.27B | $6.08B | $6.14B | $5.92B | -0.1% |
| Selling, general & admin | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | -6.8% |
| Total operating expense | $3.86B | $4.11B | $4.07B | $3.80B | $3.85B | -6.2% |
| Operating income | $2.40B | $2.16B | $2.01B | $2.35B | $2.07B | +11.5% |
| Net interest income | -$356.00M | -$357.00M | -$362.00M | -$347.00M | -$337.00M | +0.3% |
| Pre-tax income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | -0.6% |
| Tax provision | $382.00M | $409.00M | $543.00M | $322.00M | $389.00M | -6.6% |
| Net income | $1.66B | $1.65B | $1.23B | $1.87B | $1.53B | +0.4% |
| Net income to common | $1.66B | $1.65B | $1.23B | $1.87B | $1.53B | +0.4% |
| Basic EPS | 6.31 | 6.30 | 4.68 | 7.02 | 5.76 | +0.2% |
| Diluted EPS | 6.29 | 6.26 | 4.64 | 6.98 | 5.71 | +0.5% |
| EBIT | $2.61B | $2.63B | $2.18B | $2.64B | $2.36B | -0.5% |
| EBITDA | $3.27B | $3.28B | $2.90B | $3.34B | $3.04B | -0.3% |
| Basic shares | 262.99M | 262.75M | 263.46M | 265.91M | 266.18M | +0.1% |
| Diluted shares | 263.96M | 264.02M | 265.70M | 267.53M | 268.15M | -0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | -10.5% |
| Cash & short-term investments | $7.17B | $7.80B | $8.65B | $6.81B | $5.04B | -8.1% |
| Accounts receivable | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | +15.8% |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | +0.3% |
| Total current assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | +9.2% |
| Property, plant & equipment | $3.74B | $3.70B | $3.65B | $3.65B | $3.62B | +0.9% |
| Goodwill & intangibles | $72.47B | $72.85B | $73.48B | $73.90B | $73.05B | -0.5% |
| Total assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | +2.5% |
| Total current liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | +5.6% |
| Current debt | $2.79B | $1.53B | $592.00M | $3.09B | $4.29B | +82.6% |
| Long-term debt | $29.09B | $29.37B | $30.87B | $30.95B | $26.48B | -1.0% |
| Total debt | $31.88B | $30.90B | $31.46B | $34.04B | $30.77B | +3.2% |
| Total liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | +3.0% |
| Retained earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | +2.5% |
| Shareholder equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | +1.0% |
| Working capital | -$8.57B | -$9.57B | -$8.53B | -$9.72B | -$12.06B | +10.5% |
| Net tangible assets | -$29.84B | -$30.64B | -$31.77B | -$32.09B | -$32.83B | +2.6% |
| Shares issued | 263.63M | 405.90M | 404.60M | 404.47M | 404.30M | -35.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.88B | $1.86B | $1.27B | $1.97B | $1.63B | +0.8% |
| Depreciation & amortisation | $655.00M | $650.00M | $722.00M | $697.00M | $682.00M | +0.8% |
| Change in working capital | -$2.87B | -$1.06B | $3.48B | $651.00M | -$4.23B | -171.6% |
| Operating cash flow | -$421.00M | $1.13B | $6.15B | $3.42B | -$1.89B | -137.2% |
| Capital expenditure | -$297.00M | -$267.00M | -$322.00M | -$278.00M | -$285.00M | -11.2% |
| Investing cash flow | -$503.00M | -$637.00M | -$420.00M | -$4.39B | -$797.00M | +21.0% |
| Share buybacks | -$280.00M | $0 | -$1.00B | $0 | -$1.11B | — |
| Dividends paid | -$409.00M | -$417.00M | -$396.00M | -$402.00M | -$401.00M | +1.9% |
| Financing cash flow | $207.00M | -$1.14B | -$4.07B | $2.66B | -$1.33B | +118.1% |
| Free cash flow | -$718.00M | $864.00M | $5.83B | $3.14B | -$2.17B | -183.1% |
| End cash position | $6.36B | $7.08B | $7.74B | $6.07B | $4.39B | -10.2% |
Options analytics
Put / call volume
0.46
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
230.00
-16.2% from spot
ATM implied vol
0.8%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
468
Contracts, this expiry
Put volume
217
Contracts, this expiry
Heaviest call OI
250.00
0 contracts
Heaviest put OI
230.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 7.60 | 7.78 | +2.4% |
| Mar 2026 | 7.61 | 7.79 | +2.4% |
| Dec 2025 | 7.88 | 8.08 | +2.5% |
| Sep 2025 | 7.64 | 7.83 | +2.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 7.51 | 23 | $72.45B | +3.9% |
| Next quarter | 7.42 | 22 | $74.58B | +2.9% |
| Current year | 30.51 | 24 | $287.45B | +4.6% |
| Next year | 33.48 | 24 | $299.16B | +4.1% |
Analyst targets & ownership
Mean target$342.29
High target$400.00
Low target$288.00
Implied upside24.76%
Analyst count24
ConsensusBUY
Strong buy / Buy6 / 12
Hold6
Sell / Strong sell0 / 0
Held by insiders1.44%
Held by institutions92.16%
Institutions holding2.23K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
270.88
+1.29% from price
SMA 20
275.38
-0.37% from price
SMA 50
278.27
-1.40% from price
SMA 100
282.32
-2.81% from price
SMA 200
279.93
-1.99% from price
EMA 12
272.79
+0.58% from price
EMA 26
275.18
-0.29% from price
EMA 50
277.74
-1.21% from price
RSI (14)
48.8
Neutral
MACD (12,26,9)
-2.39
Hist -0.00
ATR (14)
6.97
2.54% of price
Realised vol 30D
22.5%
Annualised
Bollinger upper
287.84
20, 2σ
Bollinger lower
262.92
20, 2σ
50 / 200 cross
Death
278.27 vs 279.93
Trend bias
Below 200
-1.99%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.21
Less volatile than market
Correlation to SPY
0.09
Largely independent
Realised vol 30D
22.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-20.9%
Peak to trough
Max drawdown 5Y
-33.4%
Peak to trough
ATR 14
6.97
2.54% of price
Beta (reported)
0.30
5Y monthly, from filing
Short interest
Shares short
6.56M
Prior 5.24M
Change vs prior
+25.2%
Shorts adding
% of float
2.77%
Normal
% of shares out
2.48%
Against total outstanding
Days to cover
4.7
Liquid
Float
262.92M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Oct 1, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 4, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Aug 3, 26 | Raymond James | DOWNGRADE | Strong Buy | Outperform |
| Jul 31, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 31, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 31, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 9, 26 | Bernstein | MAINTAINED | Outperform | Outperform |
| Jun 8, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| May 26, 26 | Barclays | DOWNGRADE | Overweight | Equal-Weight |
| May 22, 26 | UBS | MAINTAINED | Buy | Buy |
| May 20, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$6.24 / yr
Forward yield2.27%
5-year avg yield1.72%
Payout ratio25.38%
Ex-dividend dateSep 8, 2026
Next pay dateSep 23, 2026
Last split3:1
Split dateJun 5, 2007
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-30
Periodic Financial Reports
10-Q · 2026-07-30
Annual report of employee stock purchase
11-K · 2026-06-24
Corporate Changes & Voting Matters
8-K · 2026-05-13
Periodic Financial Reports
10-Q · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-04-27
Annual Report to Shareholders
ARS · 2026-03-13
Corporate Changes & Voting Matters
8-K · 2026-03-03
Headlines
Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes
PR Newswire · 17h ago
2 Safe-and-Steady Stocks with Promising Prospects and 1 We Turn Down
StockStory · 2d ago
The Insurance Industry Is Shedding Jobs. It’s Not All About AI.
Barrons.com · 4d ago
3 Cash Rich US Stocks Investors Are Watching As Bond Yields Stay High
Simply Wall St. · 4d ago
Piper Sandler Adjusts Cigna Price Target to $370 From $346, Maintains Overweight Rating
MT Newswires · 5d ago
Bernstein Adjusts Cigna Price Target to $387 From $381, Maintains Outperform Rating
MT Newswires · 5d ago
How Much Downside Is Left In CVS Health Stock?
Trefis · 5d ago
Cigna Better Positioned to Meet Long-Term EPS Growth Targets, RBC Says
MT Newswires · 6d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.